The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 16, 2013

Filed:

May. 30, 2008
Applicants:

Song LI, Beijing, CN;

Jing Su, Beijing, CN;

Yao Liu, Beijing, CN;

Junhai Xiao, Beijing, CN;

Lili Wang, Beijing, CN;

Wu Zhong, Beijing, CN;

Zhibing Zheng, Beijing, CN;

Yunde Xie, Beijing, CN;

Xingzhou LI, Beijing, CN;

Guoming Zhao, Beijing, CN;

Xiaokui Wang, Beijing, CN;

Xinbo Zhou, Beijing, CN;

Hongying Liu, Beijing, CN;

Inventors:

Song Li, Beijing, CN;

Jing Su, Beijing, CN;

Yao Liu, Beijing, CN;

Junhai Xiao, Beijing, CN;

Lili Wang, Beijing, CN;

Wu Zhong, Beijing, CN;

Zhibing Zheng, Beijing, CN;

Yunde Xie, Beijing, CN;

Xingzhou Li, Beijing, CN;

Guoming Zhao, Beijing, CN;

Xiaokui Wang, Beijing, CN;

Xinbo Zhou, Beijing, CN;

Hongying Liu, Beijing, CN;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/33 (2006.01); C07D 245/00 (2006.01); C07D 245/02 (2006.01); C07D 245/04 (2006.01); C07D 245/06 (2006.01); C07D 487/02 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention relates to arene connected polyamine macrocyclic derivatives represented by general formula I, pharmaceutically acceptable salts or hydrates thereof which have anti-HIV activities, in which the definitions of substituents are as defined in the description; to preparation methods of the compounds of formula I; to pharmaceutical compositions containing the compounds of formula I or their pharmaceutically acceptable salts or hydrates; to the use of the compounds of formula I or their pharmaceutically acceptable salts or hydrates for the preparation of a medicament for the treatment and prevention of HIV-associated diseases.


Find Patent Forward Citations

Loading…